Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02368301
Title Expanded Access Treatment Protocol CA204-143
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

multiple myeloma

Therapies

Dexamethasone + Elotuzumab + Lenalidomide

Age Groups: adult
Covered Countries USA


No variant requirements are available.